Literature DB >> 16715388

Characterization of complexes between naftifine and cyclodextrins in solution and in the solid state.

Maite Uzqueda1, Carmen Martín, Arantza Zornoza, Miguel Sánchez, María Cristina Martínez-Ohárriz, Itziar Vélaz.   

Abstract

Naftifine (NF) is an antifungal drug poorly soluble in basic aqueous solutions. Complexation with cyclodextrins (CDs) improves the physicochemical characteristics of many drugs. The aim of this work is to characterize the interactions between NF and alpha-CD, beta-CD, hydroxypropylbeta-CD, methylbeta-CD, and gamma-CD. The studies have been developed in pH 12 aqueous solutions at 25 degrees C and in the solid state. The apparent stability constants of the complexes have been determined from phase-solubility diagrams. In the solid state, crystalline and amorphous complexes have been characterized using X-ray diffraction patterns, thermal analysis, and Fourier transform infrared spectroscopy. The solubility of NF improves with all the CDs studied, with the exception of alpha-CD. Different types of diagrams have been found depending on the CD used. The interaction between NF and hydroxypropylbeta-CD is stronger than that with beta-CD due to the specific properties of the substituents. The coevaporation method can be said the best method in preparing the solid complexes, except for NF-alpha-CD; again, there is no evidence of complexation. Furthermore, the presence of different types of CD structures upon complexation (i.e., cage or channel) has been discussed. Dissolution rate studies have been performed, and a positive influence of complexation in the solid state has been observed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715388     DOI: 10.1007/s11095-006-9903-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Industrial Applications of Cyclodextrins.

Authors:  Allan R. Hedges
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.

Authors:  G Zingone; F Rubessa
Journal:  Int J Pharm       Date:  2004-12-28       Impact factor: 5.875

3.  Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.

Authors:  Francesca Maestrelli; Maria Luísa González-Rodríguez; Antonio Maria Rabasco; Paola Mura
Journal:  Int J Pharm       Date:  2005-07-14       Impact factor: 5.875

4.  Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing.

Authors:  M Másson; T Loftsson; G Másson; E Stefánsson
Journal:  J Control Release       Date:  1999-05-01       Impact factor: 9.776

5.  Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin.

Authors:  Jiradej Manosroi; Maria Goretti Apriyani; Kuncoro Foe; Aranya Manosroi
Journal:  Int J Pharm       Date:  2005-04-11       Impact factor: 5.875

6.  Molecular reactivity of busulfan through its experimental electrostatic properties in the solid state.

Authors:  Nour Eddine Ghermani; Anne Spasojević-de Biré; Nouzha Bouhmaida; Souad Ouharzoune; Jérôme Bouligand; Anne Layre; Ruxandra Gref; Patrick Couvreur
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

7.  Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics.

Authors:  A Stütz; A Georgopoulos; W Granitzer; G Petranyi; D Berney
Journal:  J Med Chem       Date:  1986-01       Impact factor: 7.446

8.  Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes.

Authors:  N S Ryder; M C Dupont
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

Review 9.  Design and evaluation of cyclodextrin-based drug formulation.

Authors:  Kaneto Uekama
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-08       Impact factor: 1.645

10.  Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.

Authors:  Norased Nasongkla; Andy F Wiedmann; Andrew Bruening; Meghan Beman; Dale Ray; William G Bornmann; David A Boothman; Jinming Gao
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.580

View more
  5 in total

1.  Experimental and computational studies of physicochemical properties influence NSAID-cyclodextrin complexation.

Authors:  Linda A Felton; Carmen Popescu; Cody Wiley; Emilio Xavier Esposito; Philippe Lefevre; Anton J Hopfinger
Journal:  AAPS PharmSciTech       Date:  2014-04-10       Impact factor: 3.246

Review 2.  Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery.

Authors:  Kevin Chen; Vinam Puri; Bozena Michniak-Kohn
Journal:  AAPS J       Date:  2021-01-13       Impact factor: 4.009

3.  In Vitro Skin Permeation and Antifungal Activity of Naftifine Microemulsions.

Authors:  Meryem Sedef Erdal; Aslı Gürbüz; Seher Birteksöz Tan; Sevgi Güngör; Yıldız Özsoy
Journal:  Turk J Pharm Sci       Date:  2020-02-19

4.  Stoichiometrically Governed Curcumin Solid Dispersion and Its Cytotoxic Evaluation on Colorectal Adenocarcinoma Cells.

Authors:  Jamal Moideen Muthu Mohamed; Ali Alqahtani; Fazil Ahmad; V Krishnaraju; K Kalpana
Journal:  Drug Des Devel Ther       Date:  2020-11-02       Impact factor: 4.162

5.  Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.

Authors:  M Sedef Erdal; Gül Özhan; M Cem Mat; Yıldız Özsoy; Sevgi Güngör
Journal:  Int J Nanomedicine       Date:  2016-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.